Screening for human ADME/Tox drug properties in drug discovery

This publication has 18 references indexed in Scilit:

• Effects of cytochrome P450 inducers on 17α-ethinyloestradiol (EE₂ ) conjugation by primary human hepatocytes
  Published by Wiley ,1999
• Cryopreserved human hepatocytes: characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential
  Chemico-Biological Interactions, 1999
• The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.
  Journal of Clinical Investigation, 1998
• Managing the drug discovery/development interface
  Drug Discovery Today, 1997
• Strategic proposals for predicting drug-drug interactions during new drug development: Based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs.
  The Journal of Toxicological Sciences, 1996
• Success rates for new drugs entering clinical testing in the United States
  Clinical Pharmacology & Therapeutics, 1995
• Warnings Issued on Nonsedating Antihistamines Terfenadine and Astemizole
  Published by American Medical Association (AMA) ,1992
• The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
  Critical Reviews in Toxicology, 1992
• Optimization of Cryopreservation Procedures for Rat and Human Hepatocytes
  Xenobiotica, 1989
• A fluorometric method for determination of oxidized and reduced glutathione in tissues
  Analytical Biochemistry, 1976